Disclosure of Securities Transactions

Disclosure of securities transactions by members of the Supervisory Board and Board of Management

To comply with Section 15 a of the German Securities Trading Act, members of the Board of Management and Supervisory Board and their close relatives are required to disclose all transactions involving the purchase or sale of Bayer stock where such transactions total EUR 5,000 or more in a calendar year. The following transactions were reported to Bayer AG:

Transactions in the current fiscal year

Date/Place

Name/Function

Security

ISIN

Type of
Transaction

Price/
Currency

Quantity

Total
amount

March 5, 2014
Xetra

Dr. Paul Achleitner,
Supervisory Board

Share

DE000BAY0017

Purchase

EUR
100.68

447

EUR 45,003.96

March 5, 2014
Xetra

Dr. Clemens Börsig,
Supervisory Board

Share

DE000BAY0017

Purchase

EUR
100.68

298

EUR
30,002.64

March 5, 2014
Xetra

Thomas Ebeling,
Supervisory Board

Share

DE000BAY0017

Purchase

EUR
100.68

298

EUR
30,002.64

March 5, 2014
Xetra

Dr.-Ing. Thomas Fischer, Supervisory Board

Share

DE000BAY0017

Purchase

EUR
100.68

447

EUR
45,003.96

March 5, 2014
Xetra

Dr. Klaus Kleinfeld,
Supervisory Board

Share

DE000BAY0017

Purchase

EUR
100.68

298

EUR
30,002.64

March 5, 2014
Xetra

Dr. Helmut Panke,
Supervisory Board

Share

DE000BAY0017

Purchase

EUR
100.68

298

EUR
30,002.64

March 5, 2014
Xetra

Michael Schmidt-Kiessling, Supervisory Board

Share

DE000BAY0017

Purchase

EUR
100.68

298

EUR
30,002.64

March 5, 2014
Xetra

Sue H. Rataj, Supervisory Board

Bayer AG American Depositary
Receipt (ADR)

US 072730302

Purchase

USD
137.69

293

USD
40,343.17

March 5, 2014
Xetra

Prof. Dr. Ekkehard Schulz, Supervisory Board

Share

DE000BAY0017

Purchase

EUR
101.00

450

EUR
45,450.00

March 5, 2014
Xetra

Dr. Klaus Sturany, Supervisory Board

Share

DE000BAY0017

Purchase

EUR
100.68

596

EUR
60,005.28

March 5, 2014
Xetra

Werner Wenning, Supervisory Board

Share

DE000BAY0017

Purchase

EUR
100.68

894

EUR
90,007.92

March 5, 2014
Xetra

Prof. Dr. Ernst-Ludwig Winnacker, Supervisory Board

Share

DE000BAY0017

Purchase

EUR
100.68

298

EUR
30,002.64

Transactions in the past financial years effective 2005

2013:

Date/Place

Name/Function

Security

ISIN

Type of
Transaction

Price/
Currency

Quantity

Total
amount

December 27, 2013
Xetra

Werner Baumann, 
Board of Management    

Share

DE000BAY0017

Sale

EUR

102.872

4,600

EUR
473,211.20

November 11, 2013
Xetra

Oliver Zühlke, 
Supervisory Board    

Share

DE000BAY0017

Sale

EUR

93.88

9

EUR
844.92

November 4, 2013
Dusseldorf

Michael Schmidt-Kiessling,
Supervisory Board

Share

DE000BAY0017

Sale

EUR

92.40

90

EUR
8,316.00 

August 15,
2013
Xetra

Dr. Marijn Dekkers,
Board of Management

Share

DE000BAY0017

Purchase

EUR

85.96

6,000

EUR 515,760.00

April 23,
2013
Dusseldorf

Oliver Zühlke,
Supervisory Board

Share

DE000BAY0017

Sale

EUR

79.46

50

EUR 3,973.00

March 6,
2013
Frankfurt

Oliver Zühlke,
Supervisory Board

Share

DE000BAY0017

Sale

EUR

77.86

20

EUR 1,557.20

March 5,
2013
Xetra

Werner Wenning,
Supervisory Board

Share

DE000BAY0017

Purchase

EUR

76.12

297

EUR 22,607.79

March 5,
2013
Xetra

Dr. Paul Achleitner,
Supervisory Board

Share

DE000BAY0017

Purchase

EUR

76.12

400

EUR 30,448.20

March 5,
2013
Xetra

Dr. Clemens Börsig,
Supervisory Board

Share

DE000BAY0017

Purchase

EUR

76.12

267

EUR 20,324.17

March 5,
2013
Xetra

Thomas Ebeling,
Supervisory Board

Share

DE000BAY0017

Purchase

EUR

76.12

267

EUR 20,324.17

March 5,
2013
Xetra

Dr. Thomas Fischer,
Supervisory Board

Share

DE000BAY0017

Purchase

EUR

76.12

400

EUR 30,448.20

March 5,
2013
Xetra

Dr. Klaus Kleinfeld,
Supervisory Board

Share

DE000BAY0017

Purchase

EUR

76.12

267

EUR 20,324.17

March 5,
2013
NYSE

Sue H. Rataj,
Supervisory Board

Bayer AG American Depositary Receipt (ADR)

US0727303028

Purchase

USD 101.75

273

USD 27,777.75

March 5,
2013
Xetra

Michael

Schmidt-Kiessling,
Supervisory Board

Share

DE000BAY0017

Purchase

EUR

76.12

267

EUR 20,324.17

March 5,
2013
Xetra

Prof. Dr.-Ing.

Ekkehard D. Schulz,
Supervisory Board

Share

DE000BAY0017

Purchase

EUR

75.70

500

EUR 37,850.00

March 5,
2013
Xetra

Dr. Klaus Sturany,
Supervisory Board

Share

DE000BAY0017

Purchase

EUR

76.12

534

EUR 40,648.35

March 5,
2013
Xetra

Dr. Helmut Panke,
Supervisory Board

Share

DE000BAY0017

Purchase

EUR

76.12

267

EUR 20,324.17

March 5,
2013
Xetra

Prof. Dr. Ernst-Ludwig Winnacker,
Supervisory Board

Share

DE000BAY0017

Purchase

EUR

76.12

267

EUR 20,324.17


2012: No reportable securities transactions


2011: No reportable securities transactions


2010:

Date/
Place

Name/
Function

Security

ISIN

Type of
Transaction

Price/
Currency

Quantity

Total
amount

Jan. 4,
2010
Xetra

Werner Baumann,

Management Board

Share

DE000BAY0017

Sale

EUR 56.30

8,000

EUR 450,400.00


2009: No reportable securities transactions


2008:

Date/
Place

Name/
Function

Security

ISIN

Type of
Transaction

Price/
Currency

Quantity

Total
amount

Dec. 22,
2008
Over the
counter

Willy Beumann,
Supervisory
Board

Share

DE0005752000

Purchase

EUR 39.20

68

EUR 2,665.60

May 13,
2008
Xetra

Willy Beumann,
Supervisory
Board

Share

DE0005752000

Purchase

EUR 55.72

261

EUR 14,542.92


2007:

Date/
Place

Name/
Function

Security

ISIN

Type of
Transaction

Price/
Currency

Quantity

Total
amount

March 29,
2007
Xetra

Prof. Dr. Wolfgang Plischke,
Management Board

Share

DE0005752000

Purchase

EUR 47.70

5,300

EUR 252,810.00

January 10,
2007
Over the
counter
(Expiration
date:
May 23,
2008)

Prof. Dr. Wolfgang Plischke, Management Board

PROTECT
Discount Share
Certificate
(Underlying
instrument:
Share)

FI:
DE000SCL57K9 (Underlying instrument:
DE0005752000)

Purchase

EUR 40.12
(Strike price:
EUR 27.50 /
Price multiplier: 1)

350

EUR 14,042.00


2006: No reportable securities transactions


2005: No reportable securities transactions

Information filed with the company by members of the Board of Management and Supervisory Board shows that, on the closing date for the financial statements, their total holdings of Bayer AG stock or related financial instruments were equivalent to less than 1% of the issued stock.

Last updated: March 7, 2014  Copyright © Bayer AG
http://www.bayer.com